Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure.
Finkelstein
Yaron
Y
Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON.
Chitayat
David
D
Schechter
Tal
T
Keating
Sarah
S
Toi
Ants
A
Koren
Gideon
G
D000014:Abnormalities, Drug-Induced / Q000196:embryology / Q000453:epidemiology; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018811:Maternal Exposure; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin